MULTIPLEX HISTOPATHOLOGY-ANNUAL MEETING 2022
Multiplex Histopathology opens new horizons in phenotyping and physiopathological mechanisms in the understanding of major diseases. With reliable tools, now available on the market, it is possible to overcome previously encountered important technical difficulties.
With a widening scope of applications new challenges are emerging concerning analytical skills, multiplex data management and their scientific and medical usage.
At Cerba Research, we believe it is essential to communicate, exchange and share methods and resources in order to:
Facilitate exchange of methods to enable scientists to solve their technical difficulties.
Identify and solve technical challenges
Share tools and methods for complex multiplex data analysis
Explore scientific and medical opportunities for multiplex histopathology
Bénédicte BUTTARD, INSERM
Bénédicte Buttard has a Master degree in Biotechnology and Management from Joseph Fournier University, Grenoble.
She worked as a molecular biology technician in the Vivalis start-up in the field of antibody therapeutic in Lyon. She then spent one year as engineer in Catherine Fridman team in the Cordeliers Research Center to work on immune characterisation of clear-cell renal cell carcinoma, and two years in Jérôme Galon's Laboratory of Integrative Cancer Immunology to work on colorectal tumor microenvironment.
There, she gained knowledge in immunohistochemistry and multiplex immunofluorescence (Opal technology, Perkin Elmer and Ultivue). She is now a 2nd year PhD student "CIFRE" at Imcheck Therapeutics in collaboration with the laboratory of Integrative Cancer Immunology.
Christopher BROOKS, STEMLINE
Angela VASATURO, ULTIVUE
Speaker from FLUIDIGM
Lindsay ROSS, STEMLINE
We are expecting 7 more speakers, if you are interested in becoming a speaker at the Multiplex Histopathology Annual Meeting 2022, please contact us.